Timothy Lavin

Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial

Ivo N. van Schaik, Vera Bril, Nan van Geloven et al. · The Lancet Neurology · 2017 · 269 citations · Full text

Life Sciences, Neurology, Pharmacotherapy +11

Limbic encephalitis following immunotherapy against metastatic malignant melanoma

Sharfaraz Salam, Timothy Lavin, Ayse Turan · BMJ Case Reports · 2016 · 80 citations

Life Sciences, Neurology, Oncology +17

IgG ₁ pan-neurofascin antibodies identify a severe yet treatable neuropathy with a high mortality

Janev Fehmi, Alexander J. Davies, Jon Walters et al. · Journal of Neurology Neurosurgery & Psychiatry · 2021 · 58 citations · Full text

Medicine, Immunology, Neurology +15

Truncating Variants in <i>RFC1</i> in Cerebellar Ataxia, Neuropathy, and Vestibular Areflexia Syndrome

Riccardo Ronco, Cecilia Perini, Riccardo Curró et al. · Neurology · 2022 · 53 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Radiation treatment of benign tumors in NF2-related-schwannomatosis: A national study of 266 irradiated patients showing a significant increase in malignancy/malignant progression

D. Gareth Evans, Dorothy Halliday, Rupert Obholzer et al. · Neuro-Oncology Advances · 2023 · 35 citations · Full text

Medicine, Oncology, Radiation Oncology +16